6 sonuçlar
Arama Sonuçları
Listeleniyor 1 - 6 / 6
Yayın Attitudes of psychiatrists towards people with mental illness: a cross-sectional, multicentre study of stigma in 32 European countries(Elsevier Ltd, 2023-12) Őri, Dorottya; Szocsics, Péter; Molnár, Tamás; Bankovska Motlova, Lucie; Kazakova, Olga; Mörkl, Sabrina; Wallies, Michael; Abdulhakim, Mohamed; Boivin, Sylvie; Bruna, Krista; Cabaços, Carolina; Carbone, Elvira Anna; Dashi, Elona; Grech, Giovanni; Greguras, Stjepan; Ivanovic, Iva; Guevara, Kaloyan; Kakar, Selay; Kotsis, Konstantinos; Ingeholm Klinkby, Ida Maria; Maslak, Jovana; Matheiken, Shevonne; Mirkovic, Ana; Nechepurenko, Nikita; Panayi, Angelis; Pereira, Ana Telma Fernandes; Pomarol-Clotet, Edith; Raaj, Shaeraine; Prelog, Polona Rus; Soler-Vidal, Joan; Strumila, Robertas; Schuster, Florian; Kisand, Helena; Reim, Ann; Ahmadova, Gumru; Vircik, Matus; Yılmaz Kafalı, Helin; Grinko, Natalia; Győrffy, Zsuzsa; Rózsa,SándorBackground Mental health-related stigma occurs among the public and professionals alike. The lived experience of mental illness has been linked to less stigmatising attitudes. However, data on psychiatrists and the relationship between stigmatising attitudes and psychotherapeutic activity or case discussion groups remains scarce.Methods A cross-sectional multicentre study was performed in 32 European countries to investigate the lived experiences and attitudes of psychiatrists toward patients with mental illness as well as the relationship between stigma, psychosocial and professional factors. The self-reported, anonymous, internet-based Opening Minds Stigma Scale for Health Care Providers was used to measure the stigmatising attitudes. The survey was translated into the local language of each participating country. All participants were practising specialists and trainees in general adult or child and adolescent psychiatry. The study took place between 2nd October, 2019 and 9th July, 2021 and was preregistered at ClinicalTrial.gov (NCT04644978).Findings A total of 4245 psychiatrists completed the survey. The majority, 2797 (66%), had completed training in psychiatry, and 3320 (78%) worked in adult psychiatry. The final regression model showed that across European countries more favourable attitudes toward people with mental illness were statistically significantly associated with the lived experience of participants (including seeking help for their own mental health conditions (d = -0.92, 95% confidence interval (CI) = -1.68 to -0.15, p = 0.019), receiving medical treatment for a mental illness (d = -0.88, 95% CI = -1.71 to -0.04, p = 0.040), as well as having a friend or a family member similarly affected (d = -0.68, 95% CI = -1.14 to -0.22, p = 0.004)), being surrounded by colleagues who are less stigmatising (d = -0.98, 95% CI = -1.26 to -0.70, p < 0.001), providing psychotherapy to patients (d = -1.14, 95% CI = -1.63 to -0.65 p < 0.001), and being open to (d = -1.69, 95% CI = -2.53 to -0.85, p < 0.001) and actively participating in (d = -0.94, 95% CI = -1.45 to -0.42, p < 0.001) case discussion, supervision, or Balint groups.Interpretation Our study highlights the importance of psychotherapy training, supervision, case discussions and Balint groups in reducing the stigmatising attitudes of psychiatrists toward patients. As the findings represent cross -national predictors, Europe-wide policy interventions, national psychiatric education systems and the management of psychiatric institutions should take these findings into consideration.Funding National Youth Talent Award (Ministry of Human Resources, Hungary, (NTP-NFTo-20-B-0134). All authors received no funding for their contribution.Yayın Caring for carers: a virtual psychosocial supervision intervention to improve the quality and sustainability of mental health and psychosocial support in humanitarian contexts(Cambridge Univ. Press, 2022-06) Wells, R.; Acartuk, C.; Almeamari, F.; Alokoud, M.; Beetar, A.; Eldardery, H.; Elshazly, M.; Savluk Faruk, Ömer; Ginem, M. R.; Hadzi-Paylovic, Dusan; İlkkurşun, Z.; Jahan, S.; Joshi, R.; Klein, L.; Kurdi, Lina; Kurt, Gülan Albas; Mastrogiovanni, Chiara; Mozumder, M.; Lekkeh, S.; Nemorin, Shaun; Perry, Kathryn Nicholson; Orabi, M.; Qasim, J.; Steel, Zachery; Tavakol, Mahbube; Utah, H.; Uygun, E.; Wong, S.; Yan, L. (Fischer); Yousselr, R. Said; Zarate, Ariel; Rosenbaum, Stuart[No abstract available]Yayın Do emotional demands and exhaustion affect work engagement? the mediating role of mindfulness(Frontiers Media SA, 2024-1014) Karahan Kaplan, Merve; Bozkurt, Gözde; Aksu, Bumin Çağatay; Bozkurt, Serdar; Günsel, Ayşe; Gencer Çelik, GülşahAim: The current paper seeks to elucidate the interrelationships among emotional demands (ED), emotional exhaustion (EE), mindfulness, and work engagement (WE), with an explanation of the mediating role of mindfulness within indicated relationships. Background: Nurses working in a stress-related environment face some emotional challenges. New methods such as mindfulness should be learned; therefore, positive outcomes occur along with new developments. Method: Responses were received from nurses through a self-report questionnaire using the convenience sample technique. Four hundred and twenty-nine nurses from health institutions in Istanbul participated in the study. The PLS-SEM technique was used to test the research model. Results: ED and mindfulness, EE and mindfulness, and mindfulness and WE relationships were found. While mindfulness was a mediator between EE and WE, it was not a mediator between ED and WE. Conclusion: It has been revealed that nurses cope with job-related challenges by being present at the moment with high awareness. Furthermore, mindful nurses also foster positive outcomes. Implications for nursing management: Precautions should be taken because of the nursing shortage. It is better to provide mindfulness training to nursing students in schools before their professional lives. Implementing and using technologies might be helpful for nurses.Yayın Treatment and long-term outcome of mental disorders: The grim picture from a quasi-epidemiological investigation in 54,826 subjects from 40 countries(Elsevier Ireland Ltd, 2025-06) Fountoulakis, Konstantinos N.; Karakatsoulis, Gregory; Abraham, Seri; Adorjan, Kristina; Uddin Ahmed, Helal; Alarcòn, Renato Daniel; Arai, Kiyomi; Auwal, Sani Salihu; Berk, Michael; Levaj, Sarah; Yılmaz Kafalı, HelinIntroduction: This study registered rates of specific treatment options for mental disorders as well as their long-term outcome. Material and methods: The history of mental disorders was used as a proxy for diagnosis. The data came from the COMET-G study (40 countries; 54,826 subjects, 64.73 % females, 35.45±13.51 years old). The analysis included descriptive statistics, Risk Ratios, t-tests, and ANCOVA's. Results: 24.14 % reported a history of any mental disorder (depression >12 %, non-affective psychosis and Bipolar disorder 1 % each, >20 % self-injury, >10 % had attempted suicide, 7.17 % illegal substance abuse). Most patients were not under any kind of treatment (59.44 %) and most were not receiving treatment as recommended (e.g. 90 % of Bipolar and 2/3 of psychotic patients). No treatment at all and psychotherapy as monotherapy were consistently related to poorer outcomes. In anxiety or depression, only antidepressant monotherapy and benzodiazepines, in Bipolar disorder only antipsychotic monotherapy in males and antidepressant monotherapy in females and in non-affective psychosis antipsychotics and psychotherapy in females only, were related to good outcomes. No treatment modality was related to a good outcome in those with a history of self-harm, suicidal attempts, or illegal substance use. Only depression and treatment with antidepressants were related to metabolic syndrome. Discussion: In the community, the overwhelming majority of mental patients do not receive appropriate treatment or, even worse, no treatment at all. The outcome is unfavourable for the majority and only a few selective treatment options seem to make a difference.Yayın Differential associations between mentalizing dimensions and psychopathy subtypes: the moderating role of borderline personality traits(Frontiers Media SA, 2025-10-15) Ünver, BuketIntroduction Psychopathy comprises primary and secondary subtypes with distinct affective-interpersonal profiles. Mentalizing, i.e., the capacity to understand one's own and others' mental states, may help explain this heterogeneity. This study tested how three mentalizing dimensions (Self-Related, Other-Related, and Motivation to Mentalize) relate to psychopathy subtypes and whether borderline personality traits (BPTs) moderate these associations.Methods Adults from a community sample (N = 953) completed validated measures of psychopathy, mentalizing, and BPTs. BPTs were modeled as a continuous variable. Multivariable linear regressions predicted primary and secondary psychopathy from the three mentalizing facets while adjusting for age, gender, socioeconomic status, and psychiatric diagnosis. Moderation was examined via interaction terms between each mentalizing facet and BPTs; significant interactions were probed at -1/0/+1 SD of BPT scores.Results Higher Motivation to Mentalize and greater Self-Related Mentalizing were uniquely associated with lower primary psychopathy; Other-Related Mentalizing was not a unique predictor. For secondary psychopathy, Self-Related Mentalizing and, to a lesser extent, Motivation to Mentalize were inversely associated; Other-Related Mentalizing was not significant. BPTs significantly moderated only the association between Motivation to Mentalize and primary psychopathy (stronger inverse association at higher BPTs); no moderation effects emerged for secondary psychopathy.Conclusion Findings indicate that motivation and self-related aspects of mentalizing are protective correlates of psychopathic traits, with moderation by BPTs limited to primary psychopathy. Targeting motivation to consider mental states and strengthening self-reflective capacity may enhance psychological intervention strategies, particularly for individuals high in primary psychopathy with elevated borderline features.Yayın Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: a living systematic review with meta-analysis(Elsevier B.V., 2025-12) Højlund, Mikkel; Yılmaz Kafalı, Helin; Kırmızı, Begüm; Fusar-Poli, Paolo; Correll, Christoph U.; Cortese, Samuele; Sabé, Michel; Fiedorowicz, Jess; Saraf, Gayatri; Zein, Josephine; Berk, Michael; Husain, Muhammad I.; Rosenblat, Joshua D.; Rubaiyat, Ruby; Corace, Kim; Wong, Stanley; Hatcher, Simon; Kaluzienski, Mark; Yatham, Lakshmi N.; Cipriani, Andrea; Gosling, Corentin J.; Carhart-Harris, Robin; Tanuseputro, Peter; Myran, Daniel T.; Fabiano, Nicholas; Moher, David; Mayo, Leah M.; Nicholls, Stuart G.; White, Tracy; Prisco, Michele De; Radua, Joaquim; Vieta, Eduard; Ladha, Karim S.; Katz, Jay; Veroniki, Areti A.; Solmi, MarcoSerotonergic psychedelics and 3,4-methylendioxtmethamphetamine (MDMA) are promising treatments for mental disorders with a continuously evolving evidence base. We searched Pubmed/Scopus/clinical trial registries up to 08july2025 for double-blind randomized controlled trials (RCTs) testing MDMA or serotonergic psychedelics in patients with mental disorders. Primary outcomes were change in disease-specific symptoms and all-cause discontinuation. Standardized mean differences (SMD) and relative risk (RR) were estimated using random-effects meta-analysis. Risk of bias (RoB) was assessed with Cochrane’s RoB-tool version 2 and certainty of evidence with GRADE. The review is maintained as living systematic review ( https://ebipsyche-database.org/ ). We included 30 RCTs (1480 participants; female=45.8 %; with psychological support=83.3 %; high RoB=83.3 %). In post-traumatic stress disorder (PTSD), MDMA reduced PTSD symptoms compared to any control ( k = 11; SMD=-0.85 [-1.09; -0.60]; I2=0 %; GRADE=low). In major depressive disorder (MDD), psilocybin/ayahuasca/LSD reduced depressive symptoms ( k = 8; SMD=-0.62 [-0.97; -0.28]; I2=55 %; GRADE=very low). In anxiety disorders, both MDMA and serotonergic psychedelics reduced anxiety symptoms (SMDMDMA=-1.18 [-2.04; -0.32]; I2=0 %; k = 2; GRADE=low and SMDserotonergic=-0.88 [-1.70; -0.06]; I2=54 %; k = 5; GRADE=very low). In alcohol use disorder, neither psilocybin nor LSD reduced abstinence rates ( k = 6; RR=1.42 [0.89; 2.26]; I2=7 %; GRADE=very low). In attention-deficit hyperactivity disorder (ADHD), LSD did not reduce ADHD symptoms ( k = 1; SMD=0.22 [-0.32; 0.76]; GRADE=very low). Moderate certainty in evidence was only found for MDMA on PTSD symptoms when compared to placebo. MDMA/serotonergic psychedelics were not associated with higher risk of all-cause discontinuation (RRMDMA=0.74 [0.32; 1.72]; RRserotonergic=0.81 [0.56; 1.15]). Overall, MDMA/serotonergic psychedelics are promising for the treatment of PTSD, MDD, and anxiety disorders with moderate to large effect sizes. Pragmatic trials, long-term, head-to-head trials exploring the role of psychological support, aiming to identify predictors of response, and accounting for expectancy and functional unblinding are needed. Studies addressing these limitations will likely be required for regulatory approval of psychedelic drugs.
